Synta announces results from ganetespib Phase 2b trial on NSCLC - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Synta announces results from ganetespib Phase 2b trial on NSCLC

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

09-29-2012, 02:29 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	Synta announces results from ganetespib Phase 2b trial on NSCLC Synta Pharmaceuticals Corp. today announced results from an interim analysis of the Phase 2b portion of the GALAXY trial, a global, randomized, multi-center Phase 2b/3 study designed to evaluate the efficacy and safety of the Company's lead Hsp90 inhibitor, ganetespib, as second-line treatment for advanced non-small cell lung cancer (NSCLC). More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 07:59 AM.

free webpage hit counter